InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Connect Biopharma Holdings Ltd

CNTB Clue Score23
United States Fiscal year ends December CIK 0001835268
$0.87 -1.21% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.87 −56.06% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Sep 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−110.2Net income−168.6Fiscal year 2020Operating income−197.8Net income−779.2Fiscal year 2021Operating income−631.4Net income−1,306.8EPS, diluted−3.88Fiscal year 2022Operating income−805.6Net income−797.1EPS, diluted−2.15Fiscal year 2023Revenue0.0Operating income−69.1Net income−62.1EPS, diluted−1.13Fiscal year 2024Revenue26.0Operating income−22.5Net income−15.6EPS, diluted−0.28Fiscal year 2025Revenue0.1 −99.8%Operating income−58.1Net income−55.5EPS, diluted−1.00
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a 0.0 26.0 0.1
Growth −99.8%
Operating income −110.2 −197.8 −631.4 −805.6 −69.1 −22.5 −58.1
Net income −168.6 −779.2 −1,306.8 −797.1 −62.1 −15.6 −55.5
Growth
EPS, diluted n/a n/a −3.88 −2.15 −1.13 −0.28 −1.00
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin−86.2%Net margin−60.0%Free cash flow margin−93.6%Fiscal year 2025Operating margin−90,740.6%Net margin−86,687.5%Free cash flow margin−80,687.5%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a −86.2% −90,740.6%
Net margin n/a n/a n/a n/a n/a −60.0% −86,687.5%
Free cash flow margin n/a n/a n/a n/a n/a −93.6% −80,687.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−90.3Capital expenditure−1.1Free cash flow−91.3Fiscal year 2020Operating cash flow−167.2Capital expenditure−15.0Free cash flow−182.1Fiscal year 2021Operating cash flow−544.9Capital expenditure−24.9Free cash flow−569.9Buybacks−0.6Fiscal year 2022Operating cash flow−679.7Capital expenditure−29.3Free cash flow−709.0Buybacks0.0Fiscal year 2023Operating cash flow−47.7Capital expenditure−0.1Free cash flow−47.8Buybacks0.0Fiscal year 2024Operating cash flow−23.6Capital expenditure−0.8Free cash flow−24.4Fiscal year 2025Operating cash flow−51.2Capital expenditure−0.4Free cash flow−51.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −90.3 −167.2 −544.9 −679.7 −47.7 −23.6 −51.2
Capital expenditure −1.1 −15.0 −24.9 −29.3 −0.1 −0.8 −0.4
Free cash flow −91.3 −182.1 −569.9 −709.0 −47.8 −24.4 −51.6
Growth
Buybacks n/a n/a −0.6 0.0 0.0 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash309.0Shareholders’ equity−298.3Fiscal year 2020Cash1,010.1Shareholders’ equity−1,024.9Fiscal year 2021Cash1,706.9Shareholders’ equity1,735.8Fiscal year 2022Cash78.9Shareholders’ equity158.4Fiscal year 2023Cash105.7Shareholders’ equity101.5Fiscal year 2024Cash78.2Shareholders’ equity92.2Fiscal year 2025Cash38.3Shareholders’ equity42.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 309.0 1,010.1 1,706.9 78.9 105.7 78.2 38.3
Shareholders’ equity −298.3 −1,024.9 1,735.8 158.4 101.5 92.2 42.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
309.0 1,010.1 1,706.9 78.9 105.7 78.2 38.3
n/a n/a n/a n/a 0.0 0.8 0.0
2.5 6.9 59.3 34.7 4.3 4.0 3.8
n/a n/a 291.1 174.0 125.9 n/a n/a
Growth −40.2% −27.7%
Liabilities
n/a n/a 18.8 16.5 24.8 n/a n/a
Equity
n/a n/a −361.8 −479.8 −329.7 −345.4 −400.8
−298.3 −1,024.9 1,735.8 158.4 101.5 92.2 42.0
Growth −90.9% −35.9% −9.2% −54.5%
Per share and net cash
n/a n/a 55.1 55.0 55.1 55.3 56.4
calc n/a n/a 31.52 2.88 1.84 1.67 0.74

Lines marked calc are worked out here from filed figures; point at one for how.